I came across this workshop for "Exporting Medical Devices to the Asia Pacific" whilst perusing the internet. VCR investors in Sydney might be interested in attending to get a better idea of export potential / hurdles for medical devices. There will also be a couple of reps from VCR there. See details below.
More info at https://www.ausbiotech.org/events/details.asp?eventid=339&returnToUrl=%2Fdefault.asp
Exporting Medical Devices in the Asia-Pacific Online Registrations Close COB 22 July 2008
AusMedtech NSW is pleased to present the next export seminar‐workshop for the NSW medical device and diagnostics industry.
The workshop will be focussed on Asia‐Pacific as a particular international market.
Learn about the critical issues that every medical technology firm needs to successfully address in order to succeed in their target global market Prepare to grow your business to ensure international sales success Understand the assistance that is available from local government agencies, overseas economic development agencies and expert consultancies
The seminar will be chaired by Ash Attia, Vice President Asia Pacific Business Development with Ventracor Limited and the program will feature expert speakers on the key issues and challenges facing the global commercialisation of Aussie medical technologies. Subjects to be covered include Export Strategy; Regulatory approval; reimbursement, health technology assessments and clinical trials; Marketing, sales and distribution.
Featured Speakers include:
Lance Chia Director of Ventilation and Product Marketing, Asia Pacific, ResMed Asia Pacific Ltd Dyranda Hortle, Director of Marketing Asia Pacific, Regional Director Southern Asia, Cochlear Georgina Sanderson, Director Reimbursement, Quality, Regulatory, Cochlear Limited Asia Pacific Brett Kensett‐Smith, Intellectual Property Manager, Ventracor Limited
AusMedtech NSW is proud to present this export seminar as a ½ day workshop. There will be ample time for Q&A and discussion during the workshop.
VCR Price at posting:
0.0¢ Sentiment: Buy Disclosure: Not Held
